Monday, 16 March 2026

Obesity : The Microbiome at the Intersection of Nutrition and Pharma

With more than one billion people living with obesity worldwide—and its economic burden projected to reach $4.32 trillion annually by 2035—obesity remains one of the most pressing global health challenges of the 21st century. While GLP-1–based pharmacotherapies dominate headlines, Seventure Partners—a pioneering venture capital firm specializing in health, nutrition, and microbiome innovation through its dedicated Health for Life Capital funds—is releasing a scientific report that synthesizes global advances in gut microbiome research in obesity and metabolic health, highlighting its potential to serve as a foundation for sustainable, personalized therapeutic strategies that complement and extend conventional drug-based treatments.








A Global Health and Economic Crisis









According to the World Health Organization, 2.5 billion adults were overweight in 2022, including 890 million living with obesity. The World Obesity Atlas 2025 reports that this number has now surpassed one billion. If current trends continue, the WHO projects that 60% of adults will be affected by 2050. The World Obesity Federation estimates that the economic impact of overweight and obesity—including healthcare costs, lost productivity, and premature mortality—will reach $4.32 trillion annually by 2035, equivalent to nearly 3% of global GDP, comparable to the economic impact of COVID-19 in 2020.

 

In this context, GLP-1 (glucagon-like peptide-1) agonists have been hailed as a major breakthrough. The global market for these treatments is expected to reach $105 billion by 2030. However, this therapeutic class, as promising as it may be, also presents certain limitations that the scientific community is documenting with increasing precision.









The Limitations of Exclusively Drug based Approaches


















The Seventure Partners report highlights several unmet needs with current GLP-1 treatments. Clinical studies reveal that fewer than 50% of patients continue their treatment beyond 12 weeks, raising the critical question of result durability. Weight loss effects remain contingent on continuous medication use.

 

Furthermore, these therapies profoundly alter the intestinal ecosystem. GLP-1 agonists change how food transits through the gut and its fermentation patterns, which can disrupt microbiome composition. Other documented effects include loss of muscle mass (not just fat mass), frequent gastrointestinal disorders, and nutritional deficiencies linked to reduced appetite.









"These findings do not call into question the proven benefits of GLP-1s, but they underscore the need for complementary and supplementary approaches to ensure healthy and sustainable weight loss over the long term," the report states.









The Microbiome: An Underutilized Physiological Lever









This is precisely where the gut microbiome offers major opportunities. GLP-1 is not just a pharmaceutical molecule—it is a hormone naturally produced by L-cells in the intestine. And this production is directly modulated by the microbiome.

 

Recent scientific research demonstrates that gut microbiome metabolites—particularly short-chain fatty acids (SCFAs)—naturally stimulate GLP-1 secretion. In other words, a healthy microbiome can activate the same metabolic pathways as medications, through physiological mechanisms.

 

The Seventure Partners report thus identifies the microbiome as a cornerstone of holistic, sustainable therapeutic strategies guided by precision medicine. This approach does not aim to replace existing treatments but to complement them and optimize their long-term effectiveness.









A Rapidly Maturing Market









This convergence of microbiome and metabolism is opening a high-growth market segment. According to analyses by ResearchAndMarkets and Global Industry Analysts, the global microbiome therapeutics market is expected to grow from $1.4 billion in 2024 to $21.5 billion by 2030, representing annual growth of nearly 57%. The obesity segment shows one of the strongest dynamics with a CAGR of 56.8%, alongside opportunities in oncology, chronic and age-related diseases, and gut-brain axis applications (neurodegenerative diseases, mental health, etc.).

 

For comparison, the GLP-1 agonist market is expected to reach $105 billion by 2030 (Morgan Stanley). The 1-to-5 ratio between these two markets illustrates both the maturity of pharmacological approaches and the significant catch-up potential of microbiome-based solutions.

 

Europe shows annual growth of 35.4% in this segment (Grand View Research), driven notably by public-private partnerships and the European Commission's 2025 Biotechnology Roadmap, which prioritizes microbial therapeutics for health and sustainability.









A Broad Range of Therapeutic Innovations









Isabelle de Cremoux's analysis maps the various product categories under development in this field: fecal microbiota transplantation (FMT), Microbiome Restoration Therapy (MRT), live biotherapeutic products (LBPs), next-generation probiotics, prebiotics, postbiotics, and functional dietary fibers. These innovations follow distinct regulatory pathways and offer complementary mechanisms of action.

 

A key finding emerges from the report: the need for personalized approaches. The variability in individual responses to microbiome-based treatments requires consideration of each patient's baseline microbiome composition and functions. This heralds the advent of precision medicine applied to obesity.









Research Priorities to Be Strengthened









The report also identifies priority research areas to accelerate the clinical translation of these approaches: filling remaining mechanistic gaps, prioritizing randomized clinical trials in humans over animal experimentation, and standardizing methodologies for microbiome data collection and analysis.

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

High-Functioning Depression: Signs People Miss & How to Get Help

Image by Tim Sandle 

When most people picture depression, they imagine someone who can’t get out of bed, cries often, or withdraws completely from life.

But depression doesn’t always look like that.

Some people wake up early, go to work, meet deadlines, take care of their families, smile in meetings — and quietly struggle the entire time.

This is often referred to as high-functioning depression.

Because it hides behind productivity and responsibility, it frequently goes unnoticed — by friends, coworkers, and even the person experiencing it.

Understanding the signs can make the difference between silent suffering and meaningful support.

What Is High-Functioning Depression?

High-functioning depression is not a formal clinical diagnosis, but it often overlaps with Persistent Depressive Disorder (PDD) — a chronic, long-term form of depression.

People with this condition may:

     Maintain steady employment

     Show up socially

     Fulfill responsibilities

     Appear “put together”

Yet internally, they experience ongoing sadness, emotional numbness, low energy, or feelings of inadequacy.

Life may look stable on the outside.

Inside, it feels heavy.

Why It Often Goes Unnoticed

Unlike major depressive episodes, high-functioning depression doesn’t always interrupt daily functioning in obvious ways.

In fact, some people cope by over-functioning.

They may:

     Work longer hours

     Overcommit socially

     Strive for perfection

     Avoid slowing down

Because they are still “handling life,” they may believe their pain isn’t serious enough to deserve help.

That belief can delay treatment for years.

And over time, untreated depression often deepens.

Subtle Signs of High-Functioning Depression

The symptoms may not look dramatic — but they are real and persistent.

1. Ongoing Low Mood

A constant undercurrent of sadness, emptiness, or emotional flatness — even when life seems objectively “fine.”

2. Chronic Fatigue

Not just tired — but emotionally drained.

Getting through daily tasks requires far more effort than it appears to others.

3. Loss of Joy

Activities that once felt meaningful now feel dull. You still participate — but without genuine enjoyment.

4. Overachievement as a Coping Mechanism

Success becomes a distraction.

Staying busy prevents emotional reflection — but doesn’t resolve the underlying pain.

5. Harsh Self-Criticism

Even when accomplishing goals, there’s a persistent voice saying:

     “It’s not enough.”

     “You should be doing better.”

     “Anyone else could do this.”

6. Irritability or Emotional Withdrawal

Instead of visible sadness, depression may show up as:

     Short temper

     Emotional distance

     Reduced vulnerability

7. Sleep Changes

Trouble falling asleep. Waking too early. Or sleeping excessively but still feeling exhausted.

8. Physical Symptoms

Headaches, stomach discomfort, muscle tension, or body aches without a clear medical explanation — often connected to chronic stress.

The Hidden Cost of “Holding It Together”

High-functioning depression requires enormous internal energy.

Over time, that emotional strain can lead to:

     Burnout

     Worsening depressive symptoms

     Anxiety

     Emotional numbness

     Suicidal thoughts

According to the World Health Organization, more than 280 million people worldwide live with depression — and many never receive treatment.

Functioning does not mean thriving.

And coping does not mean healing.

Why Many People Don’t Seek Help

There are common barriers:

Stigma

Fear of being seen as weak or dramatic.

Minimizing the Pain

“I’m still working. It can’t be that bad.”

Fear of Disruption

Concerns that therapy or treatment might interfere with responsibilities.

Lack of Awareness

Not recognizing that chronic low mood qualifies as depression.

But depression doesn’t need to become debilitating before it deserves care.

When to Seek Support

Consider reaching out if you notice:

     Persistent sadness lasting more than two weeks

     Loss of interest in activities

     Ongoing fatigue not relieved by rest

     Feelings of hopelessness

     Thoughts of self-harm or suicide

Even “mild” symptoms are valid reasons to seek help.

Early intervention often prevents symptoms from worsening.

How to Get Help

Healing is possible — and support comes in many forms.

1. Therapy

Therapy provides a structured space to unpack emotional weight.

Effective approaches include:

Cognitive Behavioral Therapy (CBT): Helps identify and reframe negative thought patterns.

Interpersonal Therapy (IPT): Focuses on improving relationships and communication.

Therapy is not just for crisis. It’s for clarity and relief.

2. Medication

For some individuals, antidepressants help regulate brain chemistry.

Medication is often most effective when combined with therapy and lifestyle support.

A qualified medical provider can guide this decision.

3. Lifestyle Support

Small, consistent habits can significantly reduce depressive symptoms.

     Exercise: Research shows regular physical activity reduces depression symptoms by 20–30%.

     Nutrition: Balanced meals support brain health and energy regulation.

     Sleep hygiene: Consistent sleep schedules improve emotional regulation.

Lifestyle changes aren’t a cure — but they are powerful tools.

4. Connection and Community

Depression thrives in isolation.

Research published in PLOS Medicine shows strong social relationships increase survival rates by 50% and significantly improve resilience.

Share honestly with someone safe.

You don’t need to explain everything — just start somewhere.

5. Mindfulness and Stress Reduction

Practices like:

     Meditation

     Journaling

     Gentle yoga

     Breathwork

help regulate the nervous system and reduce rumination.

Mindfulness doesn’t erase depression — but it reduces its intensity.

Supporting Someone Who May Be Struggling

If someone in your life seems “fine” but something feels off:

     Check in regularly

     Ask open-ended questions

     Listen without trying to fix

     Avoid minimizing statements like “You’re doing great though!”

     Encourage professional support gently

Small acts — a text, a shared meal, consistent presence — matter more than you think.

Final Thoughts

High-functioning depression is often invisible.

It hides behind productivity. Behind smiles. Behind accomplishments.

But emotional pain does not need to reach a breaking point before it deserves attention.

You don’t have to wait until everything collapses to ask for help.

Reaching out is not a weakness.

  • It is self-awareness.
  • It is courage.
  • It is the beginning of healing.

With the right support, relief is possible — even if you’ve been “holding it together” for a long time.

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Special offers